Biotech News
Bio-Techne to Host Conference Call on February 4, 2026, to Announce Second Quarter Fiscal 2026 Financial Results
<div class="xn-content">
<p><span class="legendSpanClass">MINNEAPOLIS</span>, <span class="legendSpanClass">Jan. 20, 2026</span> /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday, February 4, 2026, at 8:00 a.m. CST to review its second quarter fiscal 2026 financial results.</p>
<p>Access to the discussion may be obtained as follows:</p>
<div><table border="0" cellspacing="0" cellpadding="1" class="prnbcc">
<tr>
<td class="prngen2" colspan="1" rowspan="1"><p class="prnml4"><span class="prnews_span">Time: </span></p></td>
<td class="prngen2" colspan="1" rowspan="1"><p class="prnml4"><span class="prnews_span">8:00 a.m. CST</span></p></td>
</tr>
<tr>
<td class="prngen2" colspan="1" rowspan="1"><p class="prnml4"><span class="prnews_span">Date: </span></p></td>
<td class="prngen2" colspan="1" rowspan="1"><p class="prnml4"><span class="prnews_span">February 4, 2026</span></p></td>
</tr>
<tr>
<td class="prngen2" colspan="1" rowspan="1"><p class="prnml4"><span class="prnews_span">Dial-in: </span></p></td>
<td class="prngen2" colspan="1" rowspan="1"><p class="prnml4"><span class="prnews_span">1-800-579-2543 or 1-785-424-1789 (for international callers)</span></p></td>
</tr>
<tr>
<td class="prngen2" colspan="1" rowspan="1"><p class="prnml4"><span class="prnews_span">Conference ID: </span></p></td>
<td class="prngen2" colspan="1" rowspan="1"><p class="prnml4"><span class="prnews_span">TECHQ2</span></p></td>
</tr>
<tr>
<td class="prngen2" colspan="1" rowspan="1"><p class="prnml4"><span class="prnews_span">Webcast: </span></p></td>
<td class="prngen2" colspan="1" rowspan="1"><p class="prnml4"><span class="prnews_span"> <a href="https://edge.prnewswire.com/c/link/?t=0&l=en&o=4597789-1&h=238202729&u=https%3A%2F%2Finvestors.bio-techne.com%2Fir-calendar&a=https%3A%2F%2Finvestors.bio-techne.com%2Fir-calendar" target="_blank" class="prnews_a" rel="nofollow">https://investors.bio-techne.com/ir-calendar</a></span></p></td>
</tr>
</table></div>
<p>A recorded rebroadcast will be available for interested parties unable to participate in the live conference call by dialing 1-844-512-2921 or 1-412-317-6671 (for international callers) and referencing Conference ID 11160826.</p>
<p>The replay will be available from 11:00 a.m. CST on Wednesday, February 4, 2026, until 11:00 p.m. CST on Wednesday, March 4, 2026.</p>
<p><b>About Bio-Techne<br></b>Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With hundreds of thousands of products in its portfolio, Bio-Techne generated over $1.2 billion in net sales in fiscal 2025 and has approximately 3,100 employees worldwide. For more information on Bio-Techne and its brands, please visit <a href="https://edge.prnewswire.com/c/link/?t=0&l=en&o=4597789-1&h=3554156403&u=https%3A%2F%2Fwww.bio-techne.com%2F&a=https%3A%2F%2Fwww.bio-techne.com" target="_blank" rel="nofollow">https://www.bio-techne.com</a> or follow the Company on social media at <a href="https://edge.prnewswire.com/c/link/?t=0&l=en&o=4597789-1&h=408438963&u=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fbio-techne%2F&a=LinkedIn" target="_blank" rel="nofollow">LinkedIn</a>, <a href="https://edge.prnewswire.com/c/link/?t=0&l=en&o=4597789-1&h=3394196461&u=https%3A%2F%2Fx.com%2Fbiotechne%3Flang%3Den&a=X" target="_blank" rel="nofollow">X</a>, or <a href="https://edge.prnewswire.com/c/link/?t=0&l=en&o=4597789-1&h=2122878341&u=https%3A%2F%2Fwww.youtube.com%2F%40Bio-Techne&a=YouTube" target="_blank" rel="nofollow">YouTube</a>. </p>
<div><table border="0" cellspacing="0" cellpadding="1" class="prnbcc">
<tr>
<td class="prngen2" colspan="1" rowspan="1"><p class="prnml4"><span class="prnews_span">Contact: </span></p></td>
<td class="prngen2" colspan="1" rowspan="1"><p class="prnml4"><span class="prnews_span">David Clair, Vice President, Investor Relations</span></p></td>
</tr>
<tr>
<td class="prngen2" colspan="1" rowspan="1"><br></td>
<td class="prngen2" colspan="1" rowspan="1"><p class="prnml4"><span class="prnews_span"><a href="mailto:david.clair@bio-techne.com" target="_blank" class="prnews_a" rel="nofollow">david.clair@bio-techne.com</a></span></p></td>
</tr>
<tr>
<td class="prngen2" colspan="1" rowspan="1"><br></td>
<td class="prngen2" colspan="1" rowspan="1"><p class="prnml4"><span class="prnews_span">612-656-4416 </span></p></td>
</tr>
</table></div>
<div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder9952"><p><a href="https://mma.prnewswire.com/media/2470019/Bio_Techne_Corporation__logo_Logo.html" target="_blank" rel="nofollow"><img src="https://mma.prnewswire.com/media/2470019/Bio_Techne_Corporation__logo_Logo.jpg" title="BT Logo (PRNewsfoto/Bio-Techne Corporation)" alt="BT Logo (PRNewsfoto/Bio-Techne Corporation)"></a></p></div>
<div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder0">
</div>
<p id="PURL"><img title="Cision" width="12" height="12" alt="Cision" src="https://edge.prnewswire.com/c/img/favicon.png?sn=CG65264&sd=2026-01-20"> View original content to download multimedia:<a id="PRNURL" rel="nofollow" href="https://www.prnewswire.com/news-releases/bio-techne-to-host-conference-call-on-february-4-2026-to-announce-second-quarter-fiscal-2026-financial-results-302663784.html" target="_blank">https://www.prnewswire.com/news-releases/bio-techne-to-host-conference-call-on-february-4-2026-to-announce-second-quarter-fiscal-2026-financial-results-302663784.html</a></p>
<p>SOURCE Bio-Techne Corporation</p>
</div>